Methotrexate in lieu of razoxane for incapacitating psoriasis.
D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy*; D011929:Razoxane / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000139:chemically induced
D010879:Piperazines; D011929:Razoxane; D008727:Methotrexate